Incredible Results Powered by Real Science
Life After Cancer
Empowering Stories from Immunocine Patients in Remission
Kevin C. (Stage 2C Melanoma Cancer)
From flying through the air on dirt bikes to operating heavy machinery, Kevin has always thrived in high-risk environments. But in 2022, he faced his greatest challenge yet: Stage 2C Melanoma.
With everything on the line, Kevin and his wife discovered Immunocine and delved into the science behind the Immunocine Dendritic Cell Treatment (IDCT) before ultimately applying and being approved for treatment.
Today, Kevin is completely cancer-free, with two clean scans and a clean biopsy to prove it. He credits the IDCT with not just saving his life, but also giving him a future to look forward to.
Babette L. (Stage 4 Ovarian Cancer)
Stage 4 Ovarian Cancer is often a death sentence. So when Babette was diagnosed with metastatic growth near her heart, lungs and gall bladder, she faced an incredibly daunting battle for her life.
Babette then learned about our treatment, contacted Dr. Matt Halpert and decided to undergo the IDCT. Now, nearly five years after her terminal diagnosis, she’s completely cancer free.
Testimonials
Incredible Real-World Results Backed by Real Science
Justin H. (Stage 4 Kidney Cancer)
Justin was in the prime of his life — raising three young children and in peak physical condition — when everything changed.
Diagnosed with Collecting Duct Carcinoma, an extremely rare and aggressive form of kidney cancer, Justin faced a devastating prognosis. With limited treatment options and a rapidly progressing disease, he was in a fight for his life.
After multiple surgeries and multiple recurrences just months later each time, Justin knew he needed a new approach. His search for alternative options pushed him beyond the boundaries of conventional cancer treatments.
That’s when he found Immunocine and underwent the Immunocine Dendritic Cell Treatment (IDCT). The results were remarkable — Justin’s tumor markers plummeted, giving him back his future as a devoted father and husband.
Martin L. (Stage 3B Prostate Cancer)
In 2022, almost 270,000 American men were diagnosed with prostate cancer. Due to their location within the prostate gland, traditional treatments can struggle to reach and effectively eliminate the prostate cancer cells without causing collateral damage.
So as Martin researched his options after receiving a Gleason Score of 9, he was determined to find a non-pharmacological, non-surgical and non-radiation approach, leading him to the Immunocine Dendritic Cell Treatment (IDCT) protocol). Now, more than a year following treatment, his cancer appears stable and confined.
Al M. (Stage 4 Pancreatic Cancer)
When Al was diagnosed with Stage 4 Pancreatic Cancer, his oncologist told him she’d never seen a patient with his diagnosis achieve complete remission. Al tried multiple types of chemotherapy and immunotherapy along with surgery to no measurable improvements. He began “to get his affairs in order.”
Upon completion of his treatment with Immunocine, Al quickly noticed an improvement in his health. As of December 2023, his CT scans show no signs of cancer. This chapter of his life that was consumed with pancreatic cancer is now closed.
Brock S. (Stage 4 Melanoma)
When Brock S. was diagnosed with Stage 4 Melanoma, he faced a terrifying future. With his cancer growing more than 300% after his diagnosis, Brock knew he needed to find an alternative treatment.
Starting his Immunocine treatment journey in November 2022, Brock experienced a miraculous turnaround. His mobility returned, and his more than 10 tumors started disappearing during treatment.
Brock recently celebrated his 40th birthday, a milestone he was uncertain of reaching!
Chris M. (Stage 4 Prostate Cancer)
In 2014, Chris was diagnosed with Stage 4 Prostate Cancer and immediately started Chemotherapy. By 2017, Chris was in need of a different treatment option. His cancer had spread to 30 different locations throughout his body. In addition, Chemotherapy had nearly killed him as well.
Receiving our Dendritic Cell Treatment over 7 years ago, Chris remains in remission!
Lynn R. (Triple-Negative Breast Cancer)
Despite undergoing several treatments of chemotherapy and radiation, Lynn’s cancer continued to progress and had even spread to her lungs. By March of 2022, Lynn’s cancer had been diagnosed as terminal.
To her amazement, Lynn’s rapidly growing cancer markers stabilized and decreased after treatment with Immunocine. Now nearly a year after her terminal Triple-Negative Breast Cancer diagnosis, Lynn continues to battle her cancer and defy the odds.
Kareema C. (Stage 4 Neuroendocrine Cancer)
In 2021, Kareema was diagnosed with Stage 4 Neuroendocrine Cancer. Unfortunately, her cancer continued to progress in 2022, and Kareema’s oncologists believed her cancer was now terminal.
After treatment, Kareema saw immediate success. Her cancer markers were now in normal ranges and by October her US physicians detected tumors starting to dissipate.
Sheryl H. (Stage 4 Breast Cancer)
In 2022, Sheryl’s cancer relapsed and she was diagnosed with Stage 4 Breast Cancer with metastases to her femur.
Receiving treatment in April 2022, Sheryl felt her Immune System attacking her once unresponsive tumor in her femur. By August 2022, her physicians in Canada confirmed that the tumor in her femur had been eliminated.
These testimonials are meant to be representative of possible experiences with Immunocine and the Immunocine treatment, but each individual may experience their own symptoms and outcomes and everything presented here are the patient’s own stories and not meant to imply any kind of guaranteed result.
Contact Us
Apply to See if You Qualify for Treatment.
1) Apply to See If You Qualify
If you meet the minimum requirements outlined above and are interested in seeing how our treatment could work for your specific case, please submit your info on our submission form or call us directly at +1 (888) 575-2572.
2) Schedule an Intro Call
Our team loves discussing our treatment with potential patients. We will schedule an intro call to learn about your diagnosis and answer any questions that you may have. Prior to the call, we will share additional info for you to review with your family and physician as you see fit.
3) Undergo Medical Evaluation
After confirming your eligibility, our Medical Team will perform a complimentary medical evaluation. This includes a questionnaire and review of your medical records. Once complete, you can be approved for treatment and we can build a personalized treatment program for you.
